Genetic and Epigenetic Regulation of Organic Cation Transporters
- PMID: 33674913
- DOI: 10.1007/164_2021_450
Genetic and Epigenetic Regulation of Organic Cation Transporters
Abstract
Organic cation transporters (OCTs) of the solute carrier family (SLC) 22 are the subject of intensive research because they mediate the transport of many clinically-relevant drugs such as the antidiabetic agent metformin, the opioid tramadol, and the antimigraine agent sumatriptan. OCT1 (SLC22A1) and OCT2 (SLC22A2) are highly expressed in human liver and kidney, respectively, while OCT3 (SLC22A3) shows a broader tissue distribution. As suggested from studies using knockout mice, particularly OCT2 and OCT3 appear to be of relevance for brain physiological function and drug response. The knowledge of genetic factors and epigenetic modifications affecting function and expression of OCTs is important for a better understanding of disease mechanisms and for personalized treatment of patients. This review briefly summarizes the impact of genetic variants and epigenetic regulation of OCTs in general. A comprehensive overview is given on the consequences of OCT2 and OCT3 knockout in mice and the implications of genetic OCT2 and OCT3 variants on central nervous system function in humans.
Keywords: Brain; Central nervous system; Drug response; Drug transporters; Epigenetics; Genotype–phenotype correlation; Interindividual variability; Knockout mice; OCT1; OCT2; OCT3; Organic cation transport; Pharmacogenomics; Pharmacokinetics; Single nucleotide polymorphisms.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Similar articles
-
Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.Hepatology. 2009 Oct;50(4):1227-40. doi: 10.1002/hep.23103. Hepatology. 2009. PMID: 19591196
-
Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.Handb Exp Pharmacol. 2011;(201):105-67. doi: 10.1007/978-3-642-14541-4_3. Handb Exp Pharmacol. 2011. PMID: 21103969 Review.
-
Characterization of cytochrome P450 (CYP) 2D6 drugs as substrates of human organic cation transporters and multidrug and toxin extrusion proteins.Br J Pharmacol. 2021 Mar;178(6):1459-1474. doi: 10.1111/bph.15370. Epub 2021 Feb 23. Br J Pharmacol. 2021. PMID: 33434947
-
Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).PLoS One. 2011;6(7):e22163. doi: 10.1371/journal.pone.0022163. Epub 2011 Jul 14. PLoS One. 2011. PMID: 21779389 Free PMC article.
-
Role of organic cation transporters in drug-drug interaction.Expert Opin Drug Metab Toxicol. 2015;11(10):1619-33. doi: 10.1517/17425255.2015.1069274. Epub 2015 Jul 24. Expert Opin Drug Metab Toxicol. 2015. PMID: 26206523 Review.
Cited by
-
Changes in the Sensitivity of MCF-7 and MCF-7/DX Breast Cancer Cells to Cytostatic in the Presence of Metformin.Molecules. 2024 Jul 27;29(15):3531. doi: 10.3390/molecules29153531. Molecules. 2024. PMID: 39124936 Free PMC article.
-
Transcriptional Regulation of Solute Carrier (SLC) Drug Transporters.Drug Metab Dispos. 2022 May 29;50(9):1238-50. doi: 10.1124/dmd.121.000704. Drug Metab Dispos. 2022. PMID: 35644529 Free PMC article.
-
Emerging Roles of the Human Solute Carrier 22 Family.Drug Metab Dispos. 2021 Dec 17;50(9):1193-210. doi: 10.1124/dmd.121.000702. Drug Metab Dispos. 2021. PMID: 34921098 Free PMC article.
-
Organic Cation Transporters in Psychiatric Disorders.Handb Exp Pharmacol. 2021;266:215-239. doi: 10.1007/164_2021_473. Handb Exp Pharmacol. 2021. PMID: 34282486 Free PMC article.
-
Structural insights into human organic cation transporter 1 transport and inhibition.Cell Discov. 2024 Mar 15;10(1):30. doi: 10.1038/s41421-024-00664-1. Cell Discov. 2024. PMID: 38485705 Free PMC article.
References
-
- Aoki M, Terada T, Kajiwara M, Ogasawara K, Ikai I, Ogawa O, Katsura T, Inui K-I (2008) Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation. Am J Physiol Ren Physiol 295:F165–F170. https://doi.org/10.1152/ajprenal.90257.2008 - DOI
-
- Aoyama N, Takahashi N, Kitaichi K, Ishihara R, Saito S, Maeno N, Ji X, Takagi K, Sekine Y, Iyo M, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Iwata N, Inada T, Ozaki N (2006) Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder. Alcohol Clin Exp Res 30:1644–1649. https://doi.org/10.1111/j.1530-0277.2006.00215.x - DOI - PubMed
-
- Bacq A, Balasse L, Biala G, Guiard B, Gardier AM, Schinkel A, Louis F, Vialou V, Martres M-P, Chevarin C, Hamon M, Giros B, Gautron S (2012) Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response. Mol Psychiatry 17:926–939. https://doi.org/10.1038/mp.2011.87 - DOI - PubMed
-
- Baganz NL, Horton RE, Calderon AS, Owens WA, Munn JL, Watts LT, Koldzic-Zivanovic N, Jeske NA, Koek W, Toney GM, Daws LC (2008) Organic cation transporter 3: keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc Natl Acad Sci U S A 105:18976–18981. https://doi.org/10.1073/pnas.0800466105 - DOI - PubMed - PMC
-
- Baganz N, Horton R, Martin K, Holmes A, Daws LC (2010) Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun. J Neurosci 30:15185–15195. https://doi.org/10.1523/JNEUROSCI.2740-10.2010 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials